CAS 1173239-39-8

Fórmula: C19H22ClFN4O

InChI: InChI=1S/C19H22ClFN4O/c1-23-7-13-14(8-23)15(13)9-25(19(26)18-10-24(2)11-22-18)6-12-3-4-17(21)16(20)5-12/h3-5,10-11,13-15H,6-9H2,1-2H3/t13-,14+,15?

Clave InChI: KYLOBHXXQOZRKK-YIONKMFJSA-N

SMILES: CN1C[C@@H]2[C@H](C1)C2CN(CC3=CC(=C(C=C3)F)Cl)C(=O)C4=CN(C=N4)C

PF-03463275

CAS: 1173239-39-8

PF-03463275

Fórmula: C₁₉H₂₂ClFN₄O

Pureza: ≥98%

Peso molecular: 376.86

Ref: 54-BUP00399

PF-03463275

CAS: 1173239-39-8

Fórmula: C₁₉H₂₂ClFN₄O

Peso molecular: 376.8556

Ref: IN-DA01V746

PF 03463275

CAS: 1173239-39-8

Orally available and central nervous system-penetrant inhibitor of GlyT1 glycine transporter SLC6A9. PF 03463275 was shown to enhance neuroplasticity and cognitive remediation in schizophrenia patients. In animal studies, PF 03463275 also influenced retina as changes in electroretinogram were detected in albino rats.

Fórmula: C₁₉H₂₂ClFN₄O

Pureza: Min. 95%

Peso molecular: 376.86 g/mol

Ref: 3D-FP104276

PF-03463275

CAS: 1173239-39-8

PF-03463275 is an orally active and selective reversible inhibitor of competitive glycine transporter protein-1 (GlyT1) with a Ki of 11.6 nM.PF-03463275 has CNS

Fórmula: C₁₉H₂₂ClFN₄O

Pureza: 99.95%

Forma y color: Solid

Peso molecular: 376.856

Ref: TM-T61564